Pure dysgerminoma of the ovary: a study of 31 cases

Hasna Salhi, Mohamed Ali Ayadi, Imen Bouraoui, Riadh Chargui, Khaled Rahal


Malignant germ cell tumors of the ovary are rare tumors characterized by their heterogeneity and occurring mostly in young women. Dysgerminoma is the most common type of these tumors. This was a retrospective study of 31 patients with pure dysgerminoma of the ovary diagnosed in Salah Azaiez institute of Tunis in Tunisia between 1970 and 2012.

The median age was 22 years old. Abdominal pain was the most complaint in 45.1% of cases. An abdomino-pelvic mass was found in 83.8% of cases. Surgery was performed in all patients. The median tumoral size was 13.7 cm. Sixty four-point five percent of the patients underwent a conservative surgery. The tumor was classified stage I in 51.6% of the cases, stage II in 9.7% of the cases, stage III in 35.5% of the cases and stage IV in 3.2% of the cases. Fourteen patients received platinum-based adjuvant chemotherapy, and 10 patients had a radiotherapy. We have noticed 2 cases of recurrence and 2 cases of metastasis. Five-year and ten-year overall survival was 89.4%. Five-year disease free survival was 85.2% and ten-year disease free survival was 66.3%. Dysgerminomas of the ovary have a good prognosis. The two significant prognostic factors are the stage and the postoperative residual disease.


Ovary, Germ cell, Tumor, Malignant, Dysgerminoma

Full Text:



Chen Y, Luo Y, Han C, Tian W, Yang W, Wang Y et al. Ovarian dysgerminoma in pregnancy: A case report and literature review. Cancer biology & therapy. 2018;19(8):649-58.

Krepart G, Smith J, Ruteldge F, Delclos L. The treatment for Dysgerminoma of the ovary. Cancer. 1978;41:986990.

Vicus D, Beiner ME, Klachook S, Le WL, Laframboise S, Mackay H. Pure Dysgerminoma of the ovary 35 years on: A single institutional experience. Gynecologic Oncology. 2010 ;117 :23-6.

Nasioudis D, Frey MK, Chapman-Davis E, Caputo TA, Holcomb K. Fertility-preserving surgery for advanced stage ovarian germ cells tumors. Gynecologic Oncology. 2017;147:493-6.

Newton C, Murali K, Ahmad A, Hockings H, Graham R, Liberale Vet al. Multicentre retrospective cohort study of ovarian germ cell tumours : Evidence of chemotherapy de-escalation and alignement of paediatric and adult practice. European Journal of Cancer. 2019 ;113 :19-27.

Michael K, Wampler K, Underwood J, Hansen C. Ovarian Dysgerminoma: A case study. Journal of Diagnostic Medical Sonography. 2015 ;31(5) :327-30.

Gallion H, Van nagell J, Donaldson E, Powell D. Ovarian Dysgerminoma : Report of seven cases and review of literature. Am J Obstet Gynecol. 1988;158:591-5.

Fishman Da, Schwartz Pe. Current approaches to diagnosis and treatment of ovarian germ cell malignancies. Curr Opin in Obstet Gynecol. 1994;6:98-104.

Sagae S, Kudo R. Surgery for germ cell tumors. Semin Surg Oncol. 2000;19:76-81.

Observatoire des Tumeurs Malignes Rares Gynécologiques. Référentiel -version mars. 2017. Accessed on 10th May, 2021.

Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin (BEP). J Clin Oncol. 1990;8:715-20.

Asadourian LA, Taylor MB. Dysgerminoma an analysis of 105 cases. Obstet Gynecol. 1969;33:370-3.

Alwin J, Rene C, Alexander H. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature. Gynecol Obstet. 2001;81:314-7.

Talerman A. Germ cell tumors of the ovary in blaustein’s pathology of the female genital tract. 4th ed. New York; Springer-verlag. 1995;15:860-74.

Dubrex. Histopathologie Gynécologique. 2ème éd. Paris: Masson. 1982;12:378-406.